Analyst Price Target is $16.00
▲ +207.10% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Indaptus Therapeutics in the last 3 months. The average price target is $16.00, with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 207.10% upside from the last price of $5.21.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Indaptus Therapeutics.